These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32832875)

  • 1. Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors.
    Booe JM; Warner ML; Pioszak AA
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):759-772. PubMed ID: 32832875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
    J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE; Pioszak AA
    Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
    Lee SM; Hay DL; Pioszak AA
    J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain structures of the CGRP and AM receptors.
    Kusano S; Yokoyama S
    Curr Protein Pept Sci; 2013 Aug; 14(5):375-85. PubMed ID: 23745701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.
    Takhshid MA; Poyner DR; Chabot JG; Fournier A; Ma W; Zheng WH; Owji AA; Quirion R
    Br J Pharmacol; 2006 Jun; 148(4):459-68. PubMed ID: 16702994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
    Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
    Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.
    Roehrkasse AM; Warner ML; Booe JM; Pioszak AA
    J Biol Chem; 2020 Jul; 295(28):9736-9751. PubMed ID: 32487746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
    Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
    Kunz TH; Scott M; Ittner LM; Fischer JA; Born W; Vogel J
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2155-60. PubMed ID: 17660394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells.
    Husmann K; Born W; Fischer JA; Muff R
    Biochem Pharmacol; 2003 Dec; 66(11):2107-15. PubMed ID: 14609735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
    Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
    J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
    Hay DL; Christopoulos G; Christopoulos A; Sexton PM
    Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.
    Chang CL; Hsu SYT
    PLoS One; 2019; 14(5):e0216996. PubMed ID: 31150417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.